Literature DB >> 29488821

Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

A P Hakansson1, C J Orihuela1, D Bogaert1.   

Abstract

It has long been thought that respiratory infections are the direct result of acquisition of pathogenic viruses or bacteria, followed by their overgrowth, dissemination, and in some instances tissue invasion. In the last decades, it has become apparent that in contrast to this classical view, the majority of microorganisms associated with respiratory infections and inflammation are actually common members of the respiratory ecosystem and only in rare circumstances do they cause disease. This suggests that a complex interplay between host, environment, and properties of colonizing microorganisms together determines disease development and its severity. To understand the pathophysiological processes that underlie respiratory infectious diseases, it is therefore necessary to understand the host-bacterial interactions occurring at mucosal surfaces, along with the microbes inhabiting them, during symbiosis. Current knowledge regarding host-bacterial interactions during asymptomatic colonization will be discussed, including a plausible role for the human microbiome in maintaining a healthy state. With this as a starting point, we will discuss possible disruptive factors contributing to dysbiosis, which is likely to be a key trigger for pathobionts in the development and pathophysiology of respiratory diseases. Finally, from this renewed perspective, we will reflect on current and potential new approaches for treatment in the future.

Entities:  

Mesh:

Year:  2018        PMID: 29488821      PMCID: PMC5966719          DOI: 10.1152/physrev.00040.2016

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  395 in total

1.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

2.  Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

Authors:  Susan S Huang; Richard Platt; Sheryl L Rifas-Shiman; Stephen I Pelton; Donald Goldmann; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

3.  Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.

Authors:  Brian A MacDonald; Krishnan V Chakravarthy; Bruce A Davidson; Barbara A Mullan; Ravi Alluri; Anders P Hakansson; Paul R Knight
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

4.  Increased mortality from infectious pneumonia after occupational exposure to inorganic dust, metal fumes and chemicals.

Authors:  Kjell Torén; Ingemar Qvarfordt; Ingvar A Bergdahl; Bengt Järvholm
Journal:  Thorax       Date:  2011-08-19       Impact factor: 9.139

5.  The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles.

Authors:  Mohamed S Arredouani; Zhiping Yang; Amy Imrich; Yaoyu Ning; Guozhong Qin; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-04       Impact factor: 6.914

6.  Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection.

Authors:  Monika Sharma; Sadhna Sharma; Sugata Roy; Saurabh Varma; Mridula Bose
Journal:  Immunol Cell Biol       Date:  2007-02-20       Impact factor: 5.126

7.  Effects of recombinant IL-17F intranasal inoculation against Streptococcus pneumoniae infection in a murine model.

Authors:  Ling Chen; Sheng Guo; Liangxia Wu; Chunli Hao; Wanting Xu; Jianhua Zhang
Journal:  Biotechnol Appl Biochem       Date:  2014-12-15       Impact factor: 2.431

Review 8.  Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease.

Authors:  Niv Zmora; David Zeevi; Tal Korem; Eran Segal; Eran Elinav
Journal:  Cell Host Microbe       Date:  2016-01-13       Impact factor: 21.023

9.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422

10.  Neuraminidase A-Exposed Galactose Promotes Streptococcus pneumoniae Biofilm Formation during Colonization.

Authors:  Krystle A Blanchette; Anukul T Shenoy; Jeffrey Milner; Ryan P Gilley; Erin McClure; Cecilia A Hinojosa; Nikhil Kumar; Sean C Daugherty; Luke J Tallon; Sandra Ott; Samantha J King; Daniela M Ferreira; Stephen B Gordon; Hervé Tettelin; Carlos J Orihuela
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

View more
  15 in total

Review 1.  Immunometabolism in biofilm infection: lessons from cancer.

Authors:  Rasoul Mirzaei; Niloofar Sabokroo; Yaghoub Ahmadyousefi; Hamid Motamedi; Sajad Karampoor
Journal:  Mol Med       Date:  2022-01-29       Impact factor: 6.354

Review 2.  The lung microbiome in lung transplantation.

Authors:  John E McGinniss; Samantha A Whiteside; Aurea Simon-Soro; Joshua M Diamond; Jason D Christie; Fredrick D Bushman; Ronald G Collman
Journal:  J Heart Lung Transplant       Date:  2021-05-07       Impact factor: 13.569

3.  mSphere of Influence: Adenosine in Host Defense against Bacterial Pneumonia-Friend or Foe?

Authors:  Elsa N Bou Ghanem
Journal:  mSphere       Date:  2019-07-10       Impact factor: 4.389

4.  Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum.

Authors:  Hongxing Shi; Limin Lan; Xianghong Lv; Lizhi Sun
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

Review 5.  Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease.

Authors:  Reinoud Gosens; Pieter S Hiemstra; Ian M Adcock; Ken R Bracke; Robert P Dickson; Philip M Hansbro; Susanne Krauss-Etschmann; Hermelijn H Smits; Frank R M Stassen; Sabine Bartel
Journal:  Eur Respir J       Date:  2020-08-20       Impact factor: 16.671

Review 6.  Bovine respiratory microbiota of feedlot cattle and its association with disease.

Authors:  Jianmin Chai; Sarah F Capik; Beth Kegley; John T Richeson; Jeremy G Powell; Jiangchao Zhao
Journal:  Vet Res       Date:  2022-01-12       Impact factor: 3.683

7.  Unique Roles for Streptococcus pneumoniae Phosphodiesterase 2 in Cyclic di-AMP Catabolism and Macrophage Responses.

Authors:  Alicia K Wooten; Anukul T Shenoy; Emad I Arafa; Hisashi Akiyama; Ian M C Martin; Matthew R Jones; Lee J Quinton; Suryaram Gummuluru; Guangchun Bai; Joseph P Mizgerd
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 8.786

Review 8.  Dendrimers and Dendritic Materials: From Laboratory to Medical Practice in Infectious Diseases.

Authors:  Miguel Ángel Ortega; Alberto Guzmán Merino; Oscar Fraile-Martínez; Judith Recio-Ruiz; Leonel Pekarek; Luis G Guijarro; Natalio García-Honduvilla; Melchor Álvarez-Mon; Julia Buján; Sandra García-Gallego
Journal:  Pharmaceutics       Date:  2020-09-14       Impact factor: 6.321

Review 9.  Microbiome Research and Multi-Omics Integration for Personalized Medicine in Asthma.

Authors:  Marianthi Logotheti; Panagiotis Agioutantis; Paraskevi Katsaounou; Heleni Loutrari
Journal:  J Pers Med       Date:  2021-12-05

10.  Disease burden and attributable risk factors of respiratory infections in China from 1990 to 2019.

Authors:  Zengliang Ruan; Jinlei Qi; Zhengmin Min Qian; Maigeng Zhou; Yin Yang; Shiyu Zhang; Michael G Vaughn; Morgan H LeBaige; Peng Yin; Hualiang Lin
Journal:  Lancet Reg Health West Pac       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.